Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Total
Additional Paid-in Capital
Accumulated Deficit
Class A Ordinary Shares
Class B Ordinary Shares
Beginning balance at Dec. 31, 2020 $ 6,380 $ 22,556 $ (18,620) $ 0 $ 2,444
Beginning balance (in shares) at Dec. 31, 2020       0 24,437,500
Sale of units in initial public offering, less allocation to derivative warrant liabilities 957,730,890 957,721,115   $ 9,775  
Sale of units in initial public offering, less allocation to derivative warrant liabilities (in shares)       97,750,000  
Offering costs (53,390,327) (53,390,327)      
Excess of cash receipts over the fair value of the private warrants sold to Sponsor 6,858,410 6,858,410      
Shares subject to possible redemption (903,981,360) (903,972,320)   $ (9,040)  
Shares subject to possible redemption (in shares)       (90,398,136)  
Net loss (2,223,991)   (2,223,991)    
Ending balance at Mar. 31, 2021 5,000,002 7,239,434 (2,242,611) $ 735 $ 2,444
Ending balance (in shares) at Mar. 31, 2021       7,351,864 24,437,500
Beginning balance at Dec. 31, 2020 6,380 22,556 (18,620) $ 0 $ 2,444
Beginning balance (in shares) at Dec. 31, 2020       0 24,437,500
Net loss (5,829,716)       $ (5,829,716)
Ending balance at Jun. 30, 2021 5,000,007 10,845,128 (5,848,336) $ 771 $ 2,444
Ending balance (in shares) at Jun. 30, 2021       7,712,437 24,437,500
Beginning balance at Mar. 31, 2021 5,000,002 7,239,434 (2,242,611) $ 735 $ 2,444
Beginning balance (in shares) at Mar. 31, 2021       7,351,864 24,437,500
Shares subject to possible redemption 3,605,730 3,605,694   $ 36  
Shares subject to possible redemption (in shares)       360,573  
Net loss (3,605,725)   (3,605,725)   $ (3,605,725)
Ending balance at Jun. 30, 2021 $ 5,000,007 $ 10,845,128 $ (5,848,336) $ 771 $ 2,444
Ending balance (in shares) at Jun. 30, 2021       7,712,437 24,437,500